Kratos Receives $45 Million Satellite System Related Contract Award

SAN DIEGO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security and global markets, announced today that it has recently received a new, sole source, approximate $45 million single award contract related to a new satellite system. Work under this new […]

Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision Strike Systems at AUSA 2024

SAN JUAN, Puerto Rico, Oct. 14, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc.â?¯(Nasdaq: RCAT) (“Red Cat”), a drone technology company building hardware and software for military, federal, and commercial operations, today introduced its ARACHNID(TM) family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems. Red Cat unveiled the Family of Systems at

Helio Genomics’ Methylation Model Score for Assessing Prognosis and Treatment Response in Patients with Hepatocellular Carcinoma Presented as Top Abstract at the 2024 San Antonio Liver Cancer Symposium

IRVINE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, showcased the results from their latest collaboration with Ochsner Health, demonstrating the utility of cell-free DNA (cfDNA) methylation-based biomarkers for assessing biological aggressiveness and prognosis in patients

The American Journal of Managed Care(R) and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care(R) (AJMC) to co-host a symposium focused on value-based cancer care. The event will take place on October 24, 2024, in Miami, Florida, as part of AJMC’s Institute

Freshpet, Inc. to Report Third Quarter 2024 Results on Monday, November 4, 2024

SECAUCUS, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) — Freshpet, Inc. (Nasdaq: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the third quarter ended September 30, 2024 on Monday, November 4, 2024 before market open. The Company will host a conference call with members of the executive management team to discuss these

Advanced Flower Capital Schedules Third Quarter 2024 Earnings Conference Call for November 13, 2024

WEST PALM BEACH, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (Nasdaq:AFCG) (“Advanced Flower Capital” or “AFC”) today announced that it plans to report earnings for the quarter ended September 30, 2024 on Wednesday, November 13, 2024. Advanced Flower Capital will host a conference call at 10:00 am Eastern Time on Wednesday, November

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MARIETTA, Ga., Oct. 14, 2024 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2024 after the market close on Wednesday, October 30, 2024. The MIMEDX senior management team will host a webcast and

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that the Company has been invited to present at

HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024

Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed in six presentations New data build upon the growing body of clinical evidence supporting non-invasive FFRCT technology and plaque analysis in the diagnosis and management of coronary artery disease MOUNTAIN

Freshworks to Announce Third Quarter 2024 Financial Results on November 6, 2024

SAN MATEO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the third quarter ended September 30, 2024 following the close of market on Wednesday, November 6, 2024. Freshworks will host a live audio webcast beginning at 2:00 p.m Pacific Time / 5:00 p.m. Eastern Time that

Scroll to Top